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INTRODUCTION
The ﬁrst case of granulocytic ehrlichiosis in dogs
in Slovenia was reported in 1999. Until now, a
single species of genus Anaplasma, Anaplasma
phagocytophilum (A. phagocytophilum), has been
identiﬁed in Slovenia, presumably because of
the vast extension of its vector, common hard-
bodies tick Ixodes ricinus, in this region. It has been
speculated that pathogenesis of anaplasmosis is
not entirely caused by the organism itself but may
be in part host-mediated.
Clinical manifestations of anaplasmosis range
from asymptomatic infection to death but in an
acute phase the disease most commonly presents
as an acute febrile syndrome, along with fever,
anorexia, and lymphadenopathy. The most fre-
quent laboratory ﬁndings are anaemia (mild to
severe), leukopenia with lymphopenia and neu-
tropenia followed by leukocytosis with lympho-
cytosis, and thrombocytopenia (mild to severe)
[1]. Haematological changes are similar in differ-
ent Ehrlichia species infection. Thus, it is sus-
pected that the pathogenesis of cytopenias is not
related to the infection of different target cells or
precursor cells in the bone marrow, but is prob-
ably the consequence of cytokine action and the
host’s immune response [2,3].
MATERIALS AND METHODS
From 1999 to 2006, a total of 648 dogs, considered to have
A. phagocytophilum infection, were examined at the Small
Animal Clinic, Ljubljana. Physical examination, ultrasound
examination and urinalysis were performed. Blood samples
were drawn for haematological and biochemical analysis.
Infection with A. phagocytophilum was conﬁrmed by PCR and
serology. All amplicons were subsequently subjected to direct
sequencing by using BigDye reagent chemistry. PCR was
performed on blood, targeting two genomic regions of Ehrli-
chiae and Anaplasmae: 16S rRNA gene (293 bp product) and
gene for heat shock protein (1297 bp). The presence of speciﬁc
antibodies against A. phagocytophilum was determined by
commercial indirect ﬂuorescent antibody assay (IFA).
RESULTS
A total of 682 dogs were evaluated and 481
(70.5%) were IFA positive. Only 25 (5.1%) of
them were PCR positive targeting each of the
chosen genetic regions. PCR amplicons targeting
groESL operon were puriﬁed and sequenced.
Sequencing revealed the presence of only
A. phagocytophilum, thus conﬁrming a single spe-
cies of genus Anaplasma in Slovenia [1].
Patients had mild to severe clinical manifesta-
tions of the disease. Most of them exhibited signs
of an acute febrile syndrome with elevated body
temperature or lameness. Among the haemato-
logical changes, the most prominent was throm-
bocytopenia, conﬁrmed in 71.0% of the patients;
21.4% of them had severely decreased platelet
counts (£50 · 109, Table 1). Changes in white
blood cell (WBC) counts and haematocrit were
less signiﬁcant, especially in WBC, where 9.5% of
the dogs had leukopenia, but 20.8% of the dogs
had leukocytosis. Haematocrit was lowered in
16.8% of the dogs.
DISCUSSION
Based on clinical cases, the infection of dogs with
A. phagocytophilum may cause severe chronic
disease with many clinical, haematological and
biochemical alterations, and in some cases death,
within only a few weeks, a few months, or even a
few days in acute cases. In our study, signiﬁcant
changes were noted in hematological parameters
of A. phagocytophilum seropositive dogs, with the
most prominent change in platelet counts. The
results of our study, concerning thrombocytope-
nia, coincide with the results of studies published
by other authors [1,3]. Thrombocytopenia also
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remained the most consistent haematological
abnormality during and occasionally even after
treatment. In many cases it remained life-long
although the animal was treated with doxycycline
and corticosteroids.
Correlation coefﬁcients were not statistically
determined, but based on the results of our study
we can conﬁdently recommend performing a
diagnostic test for A. phagocytophilum infection in
a dog exhibiting signs of an acute febrile syn-
drome together with lowered platelet count.
In progression, the clinical and haematological
ﬁndings in anaplasmosis may mimic leukaemia
or immune-mediated disease. The possible corre-
lation between them should be studied.
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Table 1. Changes in platelet counts (references 200–
500 · 109 ⁄L)
Rank (· 109 ⁄L) Frequency (%)
1 (0–50) 37 (22.0)
2 (51–100) 14 (8.3)
3 (101–150) 34 (20.2)
4 (151–200) 33 (19.6)
5 (201–250) 15 (8.9)
6 (251–300) 17 (10.1)
7 (301–350) 13 (7.7)
8 (351–400) 4 (2.4)
9 (401–450) 1 (0.6)
Total 168
40 Clinical Microbiology and Infection, Volume 15, Supplement 2, December 2009
 2009 The Authors
Journal Compilation  2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15 (Suppl. 2), 39–40
